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Introduction
Leptin is a protein hormone made up of 167 amino
acids synthesized by the ob gene located on the 7th
chromosome. Its major role in regulating energy
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Background: Leptin is a protein hormone secreted by adipocytes, regulating body fat and food intake. It has been
reported that serum leptin levels are high in patients with chronic renal failure, and this fact has been associated
with malnutrition and body composition changes in patients on hemodialysis. This present study investigated the
relationship between plasma leptin concentrations and body composition and markers of malnutrition in nondiabetic
patients diagnosed with end-stage chronic renal failure, treated with continuous ambulatory peritoneal dialysis (CAPD)
or hemodialysis (HD).
Methods: A total of 152 HD and 32 CAPD patients were enrolled into the study. The body compositions of the
patients were established by utilizing a Body Composition Analyzer. Triceps skinfold thickness (TSFT) was measured
by using a Harpenden Skinfold Caliper. Serum leptin level was detected by radioimmunoassay in ng/mL through
employing a DPC Gambyt-CR gamma counter. Standard laboratory methods were used for measuring the remaining
parameters (total protein, albumin, blood urea nitrogen, creatinine, hemoglobin, hematocrit, high-sensitivity C-reactive
protein [hsCRP]).
Results: No significant difference was observed between the HD and CAPD groups regarding leptin levels. Leptin
levels of female patients in both groups were markedly higher when compared with those of men (p = 0.001). Plasma
leptin levels in total, as well as for both male and female HD and CAPD patients, significantly correlated positively
with age, percent fat, fat mass, body mass index and TSFT (p = 0.001). Serum leptin levels were not found to
be correlated with length of time on dialysis, lean body mass, total body water, hsCRP, total protein and albumin
levels (p > 0.05).
Conclusion: The data obtained in this study indicated that serum leptin levels could be instrumental markers in
establishing body fat ratio, as well as in determining metabolic and nutritional factors in patients with chronic renal
failure. [J Chin Med Assoc 2005;68(12):566–570]
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expenditure and food intake has been established by
various studies carried out since its discovery.1 It is
known that leptin is a signal to the central nervous
system regarding body fat tissue stores. Leptin executes
this role through receptors in the hypothalamus.2,3
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Protein energy malnutrition is common in chronic
renal failure (CRF) and is associated with increased
mortality and morbidity. Recent studies on leptin, also
known as the obesity gene protein, have shown that it
has an endocrine function for body composition and
food intake. Serum leptin levels have been found to be
high in patients with CRF, and this outcome was
related to malnutrition and changes in body com-
position in patients on hemodialysis (HD).4–6
Various studies comparing serum leptin levels of
patients on HD with those of healthy subjects reported
higher leptin levels in HD patients.7–10 It was proposed
that this result was due to the fact that the kidney
eliminated serum leptin faster than HD. Merabet et
al8 proposed that elevated leptin levels in patients
with CRF could not be entirely justified by impaired
renal elimination as their study demonstrated low
leptin levels in 2 surgically anephric individuals. The
same writers suggested that variations in leptin
production or secondary effects of uremia may also
be causes of non-renal elimination of leptin, affecting
leptin concentrations.
A study conducted on rats indicated that plasma
leptin was cleared primarily by the kidney.11 Lack of
leptin in normal urine in that study showed that leptin
was completely catabolized from the kidneys. Minor
and unstable presence of leptin in the patients’ urine
was regarded as predictive of low molecular weight
proteinuria that could be observed during future renal
diseases. Considine et al12 demonstrated that serum
leptin concentration was correlated with body mass
index (BMI), as well as the percentage of body fat. The
correlation between leptin and body fat mass was
reported to be higher in patients with CRF when
compared to healthy individuals with normal renal
function.7
This present study investigated the relationship
between plasma leptin concentrations and body
composition and markers of malnutrition in non-
diabetic patients diagnosed with end-stage CRF,
treated with dialysis.
Methods
Subjects
A total of 152 HD patients (72 females and 80 males)
undergoing 4 hours of therapy 3 times a week using
hollow fiber hemophane dialyzers (GFS Plus 11,
Gambro, Stockholm, Sweden) and a total of 32 (15
females and 17 men) continuous ambulatory perito-
neal dialysis (CAPD) patients were enrolled into the
study. Etiologic breakdown of renal insufficiency for
the patients in the study was established as follows:
chronic glomerulonephritis (n = 41), hypertensive
nephrosclerosis (n = 40), obstructive nephropathy
(n = 23), chronic pyelonephritis (n = 27), familial
Mediterranean fever amyloidosis (n = 9), polycystic
kidney (n = 9), lupus nephritis (n = 3) and undefined
(n = 32). Patients with diabetes, liver dysfunction,
acute infection episodes, surgical operations or a his-
tory of corticosteroid use within the last 6 months
were excluded.
Blood samples and measurement
Blood samples drawn after an overnight fast were
collected in tubes containing disodium EDTA. Plas-
ma was centrifuged at 4°C and kept frozen at –40°C
until the measurement of leptin concentration.
Serum leptin level was detected by radioim-
munoassay in ng/mL through employing a DPC
Gambyt-CR gamma counter (DPC Diagnostic
Products Corporation, Los Angeles, CA, USA) at the
Department of Nuclear Medicine. A DSL-23100
ACTIVE® Leptin Coated-Tube Immunoradiometric
Assay Kit (DSL Diagnostic Systems Laboratories Inc,
Webster, TX, USA) was used to measure serum leptin
levels. Standard laboratory methods were employed
for the measurements of the remaining parameters
(total protein, albumin, blood urea nitrogen, creatinine,
hemoglobin, hematocrit, high-sensitivity C-reactive
protein [hsCRP]).
Body composition
Body fat mass and fat free mass (lean mass) were
directly measured by the Body Composition Analyzer
(Tanita Corp, Tokyo, Japan). In HD and CAPD
patients, measurement was performed after dialysis,
and body weight in this study indicates “dry weight’’.
Then BMI, fat mass index (FMI), and lean mass index
(LMI) were calculated by dividing body weight (kg),
fat mass (kg), and lean mass (kg) by the square of
height (m2), respectively.
Triceps skinfold thickness (TSFT) was measured at
halfway between the acromion process and olecranon
process in the non-fistula arm on the dorsal surface
with a Harpenden Skinfold Caliper of 1/10 sensitivity
by taking the mean value of at least 3 measurements of
15-second intervals.
Statistical analysis
Results are given as mean ± standard error (SE).
Student’s t test and Mann-Whitney U test were used
in making group comparisons. Partial correlation
coefficient was used to investigate the relationship
between groups of data (controlling for age).
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Results
Mean (± SE) plasma leptin level was 32.24 ± 2.85 ng/
mL for HD patients, and 38.23 ± 6.56 ng/mL for
CAPD patients. Leptin levels were significantly higher
in females than males in both the HD and CAPD
groups (p = 0.001). The clinical characteristics of the
subjects are shown in Table 1.
Plasma leptin levels positively correlated significantly
with age, percent fat, fat mass, BMI and TSFT in
males, females and all HD patients (p = 0.001). There
was, however, no correlation between serum leptin
levels and length of time on dialysis, lean body mass,
total body water, total protein, albumin and hsCRP
levels (p > 0.05) (Table 2).
Leptin levels correlated significantly with age,
percent fat, fat mass, BMI and TSFT in males, females
and all CAPD patients (p = 0.001). They did not,
however, correlate with length of time on dialysis, lean
body mass, total body water, total protein, albumin
and hsCRP levels (p > 0.05) (Table 2).
Discussion
The kidney is directly involved in leptin clearance.
Previous studies reported a leptin gene in the kidneys.
It has been demonstrated that in rats, leptin is cleared
by the kidneys. Furthermore, arterial-venous differences
in leptin concentrations in humans indicate that the
Table 2. Partial correlation between plasma leptin and other variables (controlling for age)
Years on dialysis Percent fat BMI TSFT FM LM TBW Albumin Total protein hsCRP
Hemodialysis
Male –0.011 0.561* 0.503* 0.288* 0.610* 0.143 0.198 –0.031 0.018 0.039
Female –0.218 0.740* 0.789* 0.628* 0.772* 0.163 0.240 0.063 0.029 0.100
Total –0.190 0.813* 0.776 0.716* 0.816* –0.177 –0.170 0.075 0.024 0.119
Continuous ambulatory peritoneal dialysis
Male –0.043 0.774* 0.725* 0.790* 0.737* –0.074 0.162 –0.132 0.014 0.003
Female –0.262 0.805* 0.598* 0.481* 0.786* –0.212 0.258 –0.150 –0.019 0.143
Total –0.277 0.656* 0.740* 0.168* 0.762* –0.407 –0.182 –0.156 –0.048 0.130
*p = 0.01. BMI = body mass index; FM = fat mass; hsCRP = high-sensitivity C-reactive protein; LM = lean body mass; TBW = total body water;
TSFT = triceps skinfold thickness.
Table 1. Clinical characteristics of hemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD) subjects*
Male Female Total
HD CAPD HD CAPD HD CAPD
Patients (n) 80 17 72 15 152 32
Age (yr) 48.96 ± 1.78 41.65 ± 2.51 53.13 ± 1.49 45.00 ± 4.62 50.93 ± 1.18 43.22 ± 2.52‡
Length of time on dialysis (mo) 61.68 ± 4.89 32.76 ± 3.63† 48.58 ± 4.50 35.80 ± 5.13 55.47 ± 3.37 34.19 ± 3.04‡
Height (cm) 167.6 ± 0.76 163.6 ± 2.45 154.6 ± 0.80 155.6 ± 1.21 161.4 ± 0.76 152.6 ± 1.82
Dry body weight (kg) 62.00 ± 1.34 59.94 ± 4.51 63.55 ± 1.83 63.36 ± 4.03 62.73 ± 1.12 61.55 ± 3.02
Body mass index (kg/m2) 22.28 ± 0.34 22.95 ± 0.80 26.53 ± 0.71 26.26 ± 1.77 24.30 ± 0.42 24.50 ± 0.96
Fat mass index (kg/m2) 3.86 ± 0.20 4.00 ± 0.58 8.81 ± 0.54 8.49 ± 1.36 6.21 ± 0.34 6.10 ± 0.80
Lean mass index (kg/m2) 18.58 ± 0.17 19.12 ± 0.52 17.72 ± 0.25 17.78 ± 0.57 18.17 ± 0.16 18.49 ± 0.30
Percent fat mass (%) 16.62 ± 0.66 16.67 ± 1.92 31.30 ± 1.27 29.57 ± 3.51 23.57 ± 0.92 22.72 ± 2.23
Body fat mass (kg) 10.89 ± 0.57 10.99 ± 1.30 21.20 ± 1.32 20.46 ± 3.15 15.77 ± 0.80 15.43 ± 1.81
Lean body mass (kg) 52.28 ± 0.65 54.60 ± 2.25 42.40 ± 0.71 42.97 ± 1.21 34.86 ± 0.46 49.15 ± 1.67
Total body water (kg) 38.28 ± 0.47 40.21 ± 1.45 31.07 ± 0.54 40.21 ± 1.45 34.86 ± 0.46 36.09 ± 1.17
Total protein (mg/dL) 6.66 ± 0.08 6.99 ± 0.17† 6.64 ± 0.08 6.69 ± 0.21 6.55 ± 0.06 6.85 ± 0.14
Albumin (g/dL) 3.57 ± 0.04 3.78 ± 0.11† 3.59 ± 0.05 3.79 ± 0.23 3.57 ± 0.03 3.78 ± 0.22‡
Serum leptin (ng/mL) 12.66 ± 2.07 22.91 ± 6.34† 54.02 ± 4.31 55.61 ± 10.53 32.25 ± 2.85 38.23 ± 6.56
High-sensitivity C-reactive protein 8.35 ± 1.05 19.07 ± 7.32 10.80 ± 2.00 11.76 ± 4.25 9.51 ± 1.09 15.64 ± 4.35
Triceps skinfold thickness (mm) 6.98 ± 0.27 7.94 ± 0.66 15.18 ± 0.92 12.13 ± 1.11 10.86 ± 0.56 9.91 ± 0.72
*Values are expressed as mean ± standard error; †p < 0.05, Mann-Whitney U test; ‡p = 0.01, Student’s t test.
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kidneys play a major role in leptin elimination. As a
result, serum leptin levels are elevated in uremia
depending on catabolic defect.11,13,14
The rate of leptin clearance from serum determines
leptin levels. Impairment of glomerular filtration in
patients with renal insufficiency leads to elevated leptin
levels, which may cause loss of appetite and protein
energy malnutrition in patients with renal insufficien-
cy.15 Malnutrition is a major comorbid condition in
patients with renal insufficiency. Despite numerous
interventions to provide nutritional support, mal-
nutrition rates are high in patients with renal in-
sufficiency.16 Various degrees of malnutrition may be
present in 40% of HD patients. This is a critical issue,
since most studies investigating nutritional status
have reported that malnutrition is correlated with
increased morbidity and mortality.5,17 Leptin levels
increase when fat mass increases. Leptin levels were
observed to be markedly higher in obese people than
in lean people. This result indicates a developed in-
sensitivity to leptin. Studies have demonstrated that
leptin levels are significantly correlated with BMI.12,18
Nishizawa et al10 investigated the correlation
between leptin levels and body composition in HD
patients. They discovered that serum leptin levels were
significantly higher in dialysis patients than in healthy
individuals. Female subjects in both groups had higher
leptin levels. Their study also compared groups with
the same percentage of body fat and reported that
leptin levels were higher in the group of HD patients
with a higher percentage of body fat. Leptin levels
correlated positively with BMI and percentage of body
fat in dialysis patients, healthy controls and all the
subjects together. A similar study conducted on
nondiabetic HD patients by Wang et al19 reported
comparable results. Serum leptin levels correlated with
body weight, BMI, body fat mass and percentage of
body fat for both genders. However, the correlation
between serum leptin and percentage of body fat was
stronger when compared with that of BMI and fat
mass. Young et al7 observed elevated leptin levels in
patients on dialysis and proposed an explanation for
this increase as being due to depressed protein intake,
lean tissue and malnutrition.
Nakazono et al9 reported significant positive cor-
relation between leptin levels and percentage of body
fat, BMI, total cholesterol, low-density lipoprotein
cholesterol and triglyceride levels in HD patients.
Their study emphasized the fact that no significant
difference existed between diabetic and nondiabetic
dialysis patients with respect to leptin levels.
Furthermore, leptin levels in diabetic patients were
demonstrated to be significantly higher in women
than in men. Merabet et al8 stated that leptin levels
were higher in patients on dialysis than in healthy
controls. They also reported correlation between lep-
tin levels and BMI, but no correlation was observed
between leptin levels and the length of time on dialysis
and patients’ weight.
We investigated leptin levels in nondiabetic patients
on CAPD and HD in our study. We examined the
relationship between leptin levels and age, gender,
method of dialysis and length of time on dialysis. We,
furthermore, studied the correlation between leptin
levels and percentage of body fat, fat mass, BMI, lean
body mass and total body water, which are elements of
body composition. Moreover, the relationships of
serum leptin level with TSFT, serum albumin and total
protein levels, which are indications of malnutrition in
patients with renal insufficiency, were investigated.
Positive significant correlations were observed be-
tween plasma leptin levels and age, percent fat, fat
mass, BMI and TSFT in HD and CAPD patients in
this study. These positive correlations could be attri-
buted to our study population: our patients all came
from poor socioeconomic backgrounds, and their
diets were composed mostly of carbohydrates but not
many available proteins. However, serum leptin levels
did not correlate with length of time on dialysis, total
body water, lean body mass, total protein, albumin
and hsCRP levels.
Male and female patients with the same percentage
of body fat were compared with respect to their leptin
levels. No significant difference in leptin levels was
noted with respect to gender in either of the dialysis
groups.
Nakazono et al9 reported that no significant cor-
relation existed between leptin levels and age, dialy-
sis time, length of time on dialysis, serum total pro-
tein and albumin levels. Likewise, Nishizawa et al10
stated that there was no significant correlation between
age and length of time on dialysis. Our study had
similar results. Previous studies comparing leptin levels
in healthy controls and in dialysis patients reported
differences between groups and with respect to gender.
Our study demonstrated higher leptin levels in female
than in male patients in both dialysis groups.
We did not establish a control group in our study.
The data were analyzed in terms of the dialysis method
employed. There are many studies demonstrating
higher leptin levels in dialysis patients when compared
with healthy individuals. Therefore, we did not enroll
healthy individuals into our study. The main purposes
of this study were to investigate leptin levels in patients
on different types of dialysis and to examine the
relationship of leptin levels to body composition, as
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well as to certain malnutrition markers, as the level of
leptin in dialysis membranes may differ, so patients
being treated with different types of dialysis may have
different body composition and malnutrition criteria.
In conclusion, we did not observe any difference in
leptin levels between the dialysis groups. The
correlations between leptin and body composition, as
well as certain malnutrition markers were similar in
both groups. The data obtained in this study indicated
that serum leptin levels could be instrumental markers
in establishing body fat ratio, as well as in determining
metabolic and nutritional factors in patients with CRF.
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